Oral flucytosine dosing in peritoneal dialysis

Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0070024. doi: 10.1128/aac.00700-24. Epub 2024 Jul 22.

Authors

Wesley D Kufel^{1

2

3}, Kumar Priyank^{2

3}

Affiliations

¹ Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.
² State University of New York Upstate Medical University, Syracuse, New York, USA.
³ State University of New York Upstate University Hospital, Syracuse, New York, USA.

PMID: 39037242
PMCID: PMC11304716 (available on 2025-01-22)
DOI: 10.1128/aac.00700-24

No abstract available

Keywords: antifungal dosing; flucytosine; peritoneal dialysis; therapeutic drug monitoring.

Publication types

Letter

MeSH terms

Administration, Oral
Aged
Antifungal Agents / administration & dosage
Antifungal Agents / therapeutic use
Female
Flucytosine* / administration & dosage
Flucytosine* / therapeutic use
Humans
Male
Middle Aged
Peritoneal Dialysis* / methods

Substances

Flucytosine
Antifungal Agents